MX359328B - Metodo para el diagnostico de enfermedad de niemann-pick. - Google Patents

Metodo para el diagnostico de enfermedad de niemann-pick.

Info

Publication number
MX359328B
MX359328B MX2014005923A MX2014005923A MX359328B MX 359328 B MX359328 B MX 359328B MX 2014005923 A MX2014005923 A MX 2014005923A MX 2014005923 A MX2014005923 A MX 2014005923A MX 359328 B MX359328 B MX 359328B
Authority
MX
Mexico
Prior art keywords
niemann
diagnosis
pick disease
subject
pick
Prior art date
Application number
MX2014005923A
Other languages
English (en)
Spanish (es)
Other versions
MX2014005923A (es
Inventor
Rolfs Arndt
Mascher Hermann
Original Assignee
Centogene Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centogene Ag filed Critical Centogene Ag
Publication of MX2014005923A publication Critical patent/MX2014005923A/es
Publication of MX359328B publication Critical patent/MX359328B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
MX2014005923A 2011-11-15 2012-11-15 Metodo para el diagnostico de enfermedad de niemann-pick. MX359328B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11009062 2011-11-15
PCT/EP2012/004756 WO2013072060A2 (en) 2011-11-15 2012-11-15 Method for the diagnosis of niemann-pick disease

Publications (2)

Publication Number Publication Date
MX2014005923A MX2014005923A (es) 2014-09-08
MX359328B true MX359328B (es) 2018-09-25

Family

ID=47221301

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014005923A MX359328B (es) 2011-11-15 2012-11-15 Metodo para el diagnostico de enfermedad de niemann-pick.
MX2018011628A MX381530B (es) 2011-11-15 2012-11-15 Método in vitro para el diagnóstico de la enfermedad de niemann-pick.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2018011628A MX381530B (es) 2011-11-15 2012-11-15 Método in vitro para el diagnóstico de la enfermedad de niemann-pick.

Country Status (11)

Country Link
US (4) US9910033B2 (enExample)
EP (1) EP2780716B1 (enExample)
JP (2) JP6243846B2 (enExample)
AU (3) AU2012339149A1 (enExample)
BR (1) BR112014009223B1 (enExample)
CA (1) CA2854668A1 (enExample)
CY (1) CY1122360T1 (enExample)
DK (1) DK2780716T3 (enExample)
IL (1) IL231982B (enExample)
MX (2) MX359328B (enExample)
WO (1) WO2013072060A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014153083A1 (en) 2013-03-14 2014-09-25 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
MX370570B (es) 2013-06-07 2019-12-17 Genzyme Corp Marcador para trastornos de la esfingomielinasa acida y sus usos.
CA3002526A1 (en) 2014-10-28 2016-05-06 Washington University Bile acid biomarkers for niemann-pick diseases, methods and uses therefor
US20180348239A1 (en) * 2014-11-19 2018-12-06 Centogene Ag Method for the Diagnosis of Niemann-Pick Disease Using a Biomarker
US10656059B2 (en) 2018-03-07 2020-05-19 Alcala Pharmaceutical, Inc. Method for qualitative and quantitative multiplexing of drug analytes from biological samples
US20190369113A1 (en) * 2018-06-01 2019-12-05 Laboratory Corporation Of America Holdings Simplified Biosample Processing for LC-MS/MS
CN111289647A (zh) * 2020-03-09 2020-06-16 广州市妇女儿童医疗中心(广州市妇幼保健院、广州市儿童医院、广州市妇婴医院、广州市妇幼保健计划生育服务中心) 葡糖鞘氨醇的检测方法
WO2024026390A2 (en) * 2022-07-28 2024-02-01 Wylder Nation Foundation Compositions and methods for diagnosing, treating, and preventing lysosomal storage diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4498918B2 (ja) * 2002-04-30 2010-07-07 生化学工業株式会社 リソソーム病の検出方法
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
US8313949B2 (en) * 2009-04-16 2012-11-20 Nextcea Inc. Detecting phospholipidosis and diagnosing lysosomal storage disorders
CA2773133A1 (en) 2009-08-28 2011-03-03 Edward H. Schuchman Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency

Also Published As

Publication number Publication date
US20180088107A1 (en) 2018-03-29
MX381530B (es) 2025-03-12
MX2014005923A (es) 2014-09-08
DK2780716T3 (da) 2019-10-14
US20220187283A1 (en) 2022-06-16
JP6711807B2 (ja) 2020-06-17
US20140309140A1 (en) 2014-10-16
WO2013072060A8 (en) 2014-07-17
AU2021204429A1 (en) 2021-07-29
US11841362B2 (en) 2023-12-12
US11231412B2 (en) 2022-01-25
IL231982A0 (en) 2014-05-28
BR112014009223A2 (pt) 2017-06-13
BR112014009223A8 (pt) 2017-06-20
AU2012339149A1 (en) 2014-04-24
CA2854668A1 (en) 2013-05-23
US10422789B2 (en) 2019-09-24
JP2018054620A (ja) 2018-04-05
US20200072819A1 (en) 2020-03-05
AU2018229451B2 (en) 2021-04-01
US9910033B2 (en) 2018-03-06
EP2780716A2 (en) 2014-09-24
IL231982B (en) 2020-01-30
CY1122360T1 (el) 2021-01-27
WO2013072060A2 (en) 2013-05-23
AU2021204429B2 (en) 2024-01-25
JP6243846B2 (ja) 2017-12-06
AU2018229451A1 (en) 2018-10-04
AU2012339149A8 (en) 2014-05-08
EP2780716B1 (en) 2019-07-31
WO2013072060A3 (en) 2013-07-25
JP2014533367A (ja) 2014-12-11
BR112014009223B1 (pt) 2021-04-06

Similar Documents

Publication Publication Date Title
MX381530B (es) Método in vitro para el diagnóstico de la enfermedad de niemann-pick.
EA201590027A1 (ru) Способы детекции заболеваний или состояний
IL289699A (en) A method for improving disease diagnosis using an analyte index
WO2013084002A3 (en) Method for detecting nucleosome adducts
BR112013001752A2 (pt) método de detectar doenças ou condições usando células fagocídicas
WO2013066369A3 (en) Methods for detecting graft-versus-host disease
IL231626A0 (en) Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage
HK1206425A1 (en) Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration
EA201391187A1 (ru) Способ диагностики злокачественной опухоли и набор для диагностики путем измерения активности nk-клеток
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
WO2013153461A3 (en) Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases
EP2495569A4 (en) METHOD FOR DETERMINING SENSITIVITY TO ANTICREME AGENT
EP2592996A4 (en) METHOD FOR DIAGNOSING WALL DIFFUSER DISORDERS
BR112015014232A2 (pt) lesão renal aguda
GB2500548B (en) Trenched sample assembly for detection of analytes
WO2011121362A3 (en) Biomarkers for major depressive disorder
GR1007816B (el) Βιολογικος δεικτης
GB201114909D0 (en) Biomarkers for lysosomal storage disorders
MX2015007494A (es) Metodo para diagnosticar leucodistrofia metacromatica.
HK1200877A1 (en) Method for monitoring, diagnosis and/or prognosis of hypoxia related disorders using nfat5
MX2018000189A (es) Metodo para el diagnostico de la enfermedad de farber.
DK2839290T3 (da) Fremgangsmåde til præsymptomatisk diagnose af cøliaki og glutensensitivitet
PT2807486T (pt) Método para a previsão in vitro, numa amostra sanguínea, da probabilidade de um paciente desenvolver dengue grave
EP2570813A4 (en) METHOD FOR THE DIAGNOSIS / PROGNOSIS OF DARM CANCER
EP2728003A4 (en) METHOD FOR DIAGNOSIS OF PANCREASTUMORS

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: CENTOGENE AG

FG Grant or registration